Company Filing History:
Years Active: 2025
Title: Miguel St-Onge: Innovator in NLRP3 Inhibition
Introduction
Miguel St-Onge is a notable inventor based in Saint-Lazare, CA. He has made significant contributions to the field of pharmaceutical innovations, particularly in the development of compounds that inhibit the NLRP3 protein. With a total of 2 patents to his name, St-Onge is recognized for his work in addressing diseases and disorders linked to this protein.
Latest Patents
St-Onge's latest patents include "Pyridazine compounds for inhibiting NLRP3" and "Compounds for inhibiting NLRP3 and uses thereof." Both patents focus on inhibitors of NLRP3 that are useful in the treatment of various diseases and disorders. These compounds are characterized by their specific chemical formula, which is detailed in the patent disclosures.
Career Highlights
Miguel St-Onge is currently associated with Ventus Therapeutics U.S., Inc., where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest to find effective treatments for conditions related to NLRP3 inhibition.
Collaborations
St-Onge collaborates with talented professionals in his field, including Stéphane Dorich and Jason Burch. These partnerships enhance the innovative potential of his research and contribute to the success of their projects.
Conclusion
In summary, Miguel St-Onge is a dedicated inventor whose work on NLRP3 inhibitors holds promise for the treatment of various diseases. His contributions to the field of pharmaceutical innovation are noteworthy and continue to impact the industry positively.